Cognetivity Neurosciences Ltd. announced a collaboration with UC Health, one of the leading healthcare systems in the United States, to improve early detection of cognitive impairment in clinical settings in the USA. Centred in Cincinnati, Ohio, UC Health is one of the highest rated healthcare providers in the USA. Recognized for excellence and backed by the academic strength of the University of Cincinnati, one of the nation's top 25 public research universities, UC Health is revolutionizing how discovery-driven care is delivered.

Its multidisciplinary teams of trained professionals and experts deliver nationally recognized care to more than 500,000 patients from all 50 states each year. Under this commercial agreement, Cognetivity will provide UC Health's UC Gardner Neuroscience Institute with access to its AI powered CognICATM cognitive assessment tool to allow evaluation of their patients' brain health at both primary and secondary care, enabling regular assessments to provide the best possible standard of care. CognICA is a fast, accurate, and repeatable tool that can be used to assess cognitive function in patients of different ages and backgrounds, both at home and in the clinic.

By being able to measure brain function regularly, reliably and with precision, the UC Gardner Neuroscience Institute can deliver the best possible quality care for their patients' brains, the most important organ in the body, but one that is sadly frequently overlooked. UC Health will use CognICA to screen patients at risk for cognitive impairment, including seniors and those with cancer, and neurosurgery conditions. Patients who screen positive on CognICA will be referred to the UC Gardner Neuroscience Institute's Memory Disorders Center for further evaluation and diagnosis, allowing detection and treatment to take place as early as possible, when it is at its most effective.